Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination With Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines

Advances in Clinical and Experimental Medicine - Poland
doi 10.17219/acem/32934